Table 2

Prevalence of genital tract infections at baseline in adolescents in comparison with other age categories

All women
(n=752)
15–19 years
(n=180)
20–24 years
(n=291)
>25 years
(n=281)
20–24 vs 15–19 years (ref)>25 vs 15–19 years (ref)
OR (95% CI)
P value
OR (95% CI)
P value
Trichomonas vaginalis, n (%)
(95% CI)
115 (15.1)
(13.0 to 18.2)
20 (11.1)
(7.0 to 16.9)
50 (17.2)
(13.0 to 22.0)
45 (16.0)
(12.1 to 21.1)
1.6 (0.9 to 2.8)
0.09
1.5 (0.9 to 2.7)
0.17
Neisseria gonorrhoeae, n (%)
(95% CI)
43 (5.7)
(4.3 to 7.7)
8 (4.4)
(2.0 to 8.7)
17 (5.8)
(3.4 to 9.2)
18 (6.4)
(3.9 to 10.0)
1.3 (0.6 to 3.1)
0.57
1.5 (0.6 to 3.4)
0.42
Chlamydia trachomatis, n (%)
(95% CI)
73 (9.8)
(7.9 to 12.1)
14 (7.8)
(4.4 to 12.9)
33 (11.3)
(7.9 to 15.6)
26 (9.3)
(6.2 to 13.4)
1.5 (0.8 to 2.9)
0.27
1.2 (0.6 to 2.4)
0.62
Mycoplasma genitalium, n (%)
(95% CI)
26 (3.5)
(2.4 to 5.1)
9 (5.0)
(2.4 to 9.4)
7 (2.4)
(1.0 to 4.9)
10 (3.6)
(1.8 to 6.5)
0.5 (0.2 to 1.3)
0.19
0.7 (0.3 to 1.8)
0.48
Treponema pallidum, n (%)
(95% CI)
4 (0.5)
(0.2 to 1.4)
0 (0.0)1 (0.3)
(0.01 to 1.9)
3 (1.1)
(0.2 to 3.1)
NN/A
Any STI, n (%)
(95% CI)
244 (32.5)
(29.2 to 35.9)
48 (26.7)
(20.4 to 33.8)
101 (34.7)
(29.3 to 40.5)
95 (33.8)
(28.3 to 39.7)
1.4 (1.0 to 2.1)
0.09
1.4 (0.9 to 2.1)
0.12
Bacterial vaginosis, n (%)
(95% CI)
280 (37.5)
(34.1 to 41.1)
63 (35.0)
(28.4 to 42.9)
107 (36.8)
(31.4 to 42.9)
110 (39.2)
(33.7 to 45.4)
1.1 (0.7 to 1.6)
0.77
1.2 (0.8 to 1.8)
0.37
  • STI, sexually transmitted infection.